The arrival of Retatrutide read more ZPHC, at a concentration of 120mg, is generating considerable excitement within the medical community. This novel dual GIP and GLP-1 agonist medication appears to provide impressive improvements in weight loss compared to current therapies. Preliminary research studies have shown significant reductions in weight